EuroBiO 2008, (www.eurobio2008.com), THE Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congrès conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive. During these three days, the international life science community will be brought together around the Four Pillars that made the success of BIO in the US: the Conference Pillar, the Business Convention Pillar, the Career Fair Pillar, and the Exhibition Pillar.
The international keynote speakers who will share their thoughts on the challenges facing the life sciences include:
- Michèle Boccoz, Directrice de la Communication Internationale, Veolia Environment;
- Philippe Busquin, Former European Commissioner for Research; Member of The European Parliament;
- Martine Charbonnier, Executive Director, European Listing, NYSE Euronext;
- Anne–Lise Borresen Dale, President, European Association of Cancer Research;
- Willy de Greef, Secretary–General of EuropaBiO; former head of Regulatory Affairs, Syngenta Seeds; former CEO, D1 Oils;
- Malcolm Elliott, Founder and Executive Director, The Norman Borlaug Institute for Crop Improvement;
- Iain Gillespie, Head of the Biotechnology Division, OECD;
- Angel Gurria, Secretary–General, Organisation for Economic Co–operation and Development (OECD);
- Harriet Wallberg Henriksson, President, Karolinska Institutet; Member of Karolinska Institutet´s Nobel Assembly;
- Stéphane Hogan, Head of Unit – Horizontal Aspects & Coordination, Directorate F – Health, DG Research, The European Commission;
- Wayne Jones, Head, Trade and Agriculture Directorate, Agriculture and Development Division, Organisation for Economic Co–operation and Development (OECD);
- Alastair Kent, President of European Genetic Alliances´ Network (EGAN); Director, Genetic Interest Group;
- Cathy Kinney, President & co–Chief Operating Officer, NYSE Euronext;
- Patrik Klintbom, Coordinator of Alternative Fuels, Volvo Technologies;
- Jonathan Knowles, President of Group Research, Member of the Executive Committee, Roche; Member of the Board of Genentech; Chair of EFPIA´s Research Director´s Group; Chairman of the Governing Board of the Innovative Medicines Initiative (IMI);
- Sir Peter Lachmann, FRS FMedSci; Emeritus Sheila Joan Smith Professor of Immunology in the University of Cambridge; President Emeritus of the Federation of European Academies of Medicine; Former President of the UK Academy of Medical Sciences;
- Chung–Cheng Liu, Director General Biomedical Engineering Research Lab ITRI, Taiwan;
- Thomas Lönngren, Executive Director, European Medicines Agency (EMEA);
- Federico Mayor, Co–Chair of the UN High Level Group on the Alliance Civilizations; Former Director General, UNESCO;
- Osamu Nagayama, Chairman of the Board of Directors, President and Chief Executive Officer, Chugai; former President, Japan Pharmaceutical Manufacturers Association (JPMA);
- Roberto Rodrigues, Former Brazilian minister of Agriculture; Co–chairman of the InterAmerican Ethanol Commission (IEC); Coordinator of the Getulio Vargas Foundation Agribusiness Center (GV Agro); and President of the Superior Council of Agribusiness of São Paulo´s Federation of Industries (FIESP);
- Steen Riisgaard, President & Chief Executive Officer, Novozymes; Chairman, EuropaBio;
- Pedro de Sampaio Nunes, Former Portuguese State Secretary for Science and Innovation; CEO Green Cyber, Portugal;
- Albert Sasson, Senior Visiting Professor, The United Nations University UNU–IAS;
- Zoran Stancic, Deputy Director General – Scientific Advances, Research Directorate General, The European Commission;
- Stephan B. Tanda, Member of the Board, DSM;
- Christos Tokamanis, Head, Operational Unit Nanosciences and Nanotechnologies, European Commission;
- Avigad Vonshak, Director, The Jacob Blaustein Institute for Desert Research (BIDR), Ben–Gurion University of the Negev, Israel.
We sincerely hope to see you at this 2008 edition of THE Life Sciences Event.
Please contact Caroline Carmagnol (caroline@alizerp.com) or Arnaud Bertrand (arnaud@alizerp.com), for your press accreditation.
About EuroBiO
Founded in 1997 on the initiative of the French Ministry of Research, the then called European Biotech Crossroads has rapidly succeeded in bringing together all the biotechnology actors and stakeholders: life science companies, start–up projects, students, researchers, private & public–sector research organizations, industry bodies, investors, consulting firms, multinationals from the biotech, pharmaceutical, diagnostics, agrifood & environmental sectors, local authorities, clusters, bioparks, bioincubators, public authorities and regulatory bodies.
In 2006, the European Biotech Crossroads took place in Paris for its 10th anniversary. Under the guidance of Eric Poincelet, former Director General of The World Life Sciences Forum BioVision and founder of BioSquare, the Event was totally transformed on this occasion and remodelled according to the US BIO structure: Four Pillars, Three Sectors, and Three Generations. To reflect this transformation into what is set to become "The European BIO", the name EuroBiO was adopted. Over 4,000 experts already joined in the newly "revamped" EuroBiO in 2006. And over 5,000 are expected for this EU Presidency Edition 2008.
EuroBiO is now a truly international event, with a prime focus on European issues. The Event is dedicated to Life Sciences in general – and in particular, to biotech´s three major fields of application – Health, Environment and Agro–industry.
The overall setting of EuroBiO 2008 was awarded to Paris and Region Ile–de–France; the concrete organization of the event is ensured by its Regional Economic Development Agency for Paris Ile–de–France (ARD) and its Partner, Package Organization.
With the support of :
UE2008.fr
Conseil Général de Seine–Saint–Denis
Mairie de Paris
Conseil Général de l´Essonne
